#LCSM Chat Topic 11/20 (8 PM EST): Know Your Radon Risk
What action would you take to protect your family if you suspected a killer was in your home?
Radon gas is odorless, colorless, and classified as a human carcinogen by the World Health Organization, US National Academy of Sciences, US Department of Health and Human Services, and US Environmental Protection Agency (EPA).
Approximately 21,000 Americans will die from radon-induced lung cancer this year. Indoor exposure to radon gas is the second greatest known risk factor for lung cancer. Radon exposure is a threat significant enough that nine federal agencies worked together to release the Federal Radon Action Plan in 2013.
The topic for our November 20 #LCSM Chat (8 PM EST) will focus on understanding what radon gas is, how to determine your risk, and how to reduce your risk at home. For this chat, we will be joined by some special guests:
- Dusty Donaldson (@dustywater) is a lung cancer survivor and founder of the Dusty Joy Foundation.
- Angel Price (@Angel4CanSAR) has over 20 years experience in the radon industry. She currently serves as the Associate Director of Cancer Survivors Against Radon (CanSAR).
- Shawn Price (@PriceRadon) has 25 years of experience in radon testing procedures, quality control, laboratory operations, education, and public policy advocacy. He is the President of American Association of Radon Scientists and Technologists (AARST).
Our moderator Janet Freeman-Daily (@JFreemanDaily) will lead our discussion using the topics below. You can learn more about #LCSM Chat and how to join it here.
T1: What is radon gas? Why should we care about it?
T2: How can people determine if radon is a concern for them?
T3: How can people reduce indoor radon gas levels in their homes and businesses?
T4: How can we help more people learn about dangers of radon gas and how to reduce their risk?
Resources
- NCI Factsheet: Radon and Cancer
- Order a Radon Test Kit
- US Environmental Protection Agency (EPA) Citizens Guide to Radon
- Kansas State University comprehensive site about radon
- EPA Radon Map
Thanks to Dusty Donaldson of the Dusty Joy Foundation for help with researching information for this post.
Special #LCSM Chat Topic 11/05 1 PM ET: @TheNCI hosts chat on precision medicine in lung cancer
#LCSM Chat is pleased to announce a special #LCSM Chat for Lung Cancer Awareness Month will be held on WEDNESDAY, November 5 at 1 PM Eastern Time (NOT our usual day and time). The National Cancer Institute (@theNCI) and a panel of experts will be using the #LCSM hashtag to talk about exciting new lung cancer treatment options!
This chat will be in question-and-answer format, with a panel of experts addressing specific topics posed by @theNCI as well as fielding audience questions related to those topics. This format is great for patients, caregivers, medical personnel and advocates regardless of their previous experience with tweetchats. We hope you’ll join us! (Check out our refresher on how to join a tweetchat)
Below is NCI’s announcement about the November 5 Chat.
On Wednesday, November 5 from 1:00-2:00 ET, the National Cancer Institute (@theNCI) will be hosting a Twitter chat on precision medicine in lung cancer using the #LCSM hashtag.
We’ll have a “who’s who” of precision medicine lung cancer experts on the chat, including:
- Dr. David Gerber, Lung Cancer Specialist, UT Southwestern Medical Center
- Ryan M. Hohman, JD, Managing Director, Policy & Public Affairs, Friends of Cancer Research
- Dr. Shakun Malik, Head, Thoracic Cancer Therapeutics in the Clinical Investigations Branch of the Cancer Therapy Evaluation program at the National Cancer Institute
- Kim Norris, Founder/President, Lung Cancer Foundation of America
- Dr. Geoffrey R. Oxnard, MS, Instructor in Medicine, Harvard Medical School
- Dr. Vassiliki Papadimitrakopoulou, M.D., Professor, Department of Thoracic/Head and Neck Medical Oncology, at the University of Texas MD Anderson Cancer Center, Houston, TX
During the chat, the experts will be discussing, among other topics, how lung cancer treatment has changed over the last few years, provide more information about the definition of “precision medicine” as it applies to lung cancer, discuss when patients might consider a clinical trial, as well as provide more background and specifics on the Lung-MAP and ALCHEMIST clinical trials.
For more background information on Lung-MAP, we also recommend Friends of Cancer Research’s “What Leaders in the Field are Saying About Lung-MAP.”
#LCSM 
You must be logged in to post a comment.